NM-001

NM-001 is a theranostic prodrug that targets ανβ3 integrin. NM-001 consists of cRGD and GFLG peptides, a DCM fluorophore and Chlorambucil (HY-13593) . NM-001 internalizes into lysosomes of tumor cells via the cRGD peptide, and generates NM-002 (HY-178820) and Chlorambucil through intracellular cleavage at the GFLG peptide by overexpressed Cathepsin B (CTSB) . NM-001 exhibits green fluorescence under physiological conditions, and converts to NIR fluorescence by CTSB activation. NM-001 has significant antitumor activity with low toxicity in HeLa cell xenografts mouse models. NM-001 can be used for real-time drug release monitoring research[1].

Product Specifications

UNSPSC

12352005

Target

Drug Intermediate; Integrin

Related Pathways

Cytoskeleton; Others

Field of Research

Cancer

Smiles

CC(C)(C1=C(C=C(C/2=C1)OC(/C=C/C3=CC(Cl)=C(C(COC(CCCC4=CC=C(C=C4)N(CCCl)CCCl)=O)=C3)OCC5=CC=C(C=C5)NC(CNC([C@H](NC([C@H](NC(CN)=O)CC6=CC=CC=C6)=O)CC(C)C)=O)=O)=CC2=C(C#N)\C#N)OCCOCCOCCOCCN7N=NC(CCC(NCCCC[C@@H](C(N[C@H]8CCCNC(N)=N)=O)NC([C@H](NC([C@@H](NC(CNC8=O)=O)CC(O)=O)=O)CC9=CC=C(C=C9)O)=O)=O)=C7)C